1. |
Cassiman C, Casteels I, Stalmans P, et al. Optical coherence tomography angiography of retinal microvascular changes overlying choroidal nodules in neurofibromatosis type 1[J]. Case Rep Ophthalmol, 2017, 8(1): 214-200. DOI: 10.1159/000469702.
|
2. |
Neurofibromatosis. Conference statement: national institutes of health consensus development conference[J]. Arch Neurol, 1988, 45(5): 575-578. DOI: 10.1001/archneur.1988.00520290115023.
|
3. |
Huson S, Jones D, Beck L. Ophthalmic manifestations of neurofibromatosis[J]. Br J Ophthalmol, 1987, 71(3): 235-238. DOI: 10.1136/bjo.71.3.235.
|
4. |
Nichols JC, Amato JE, Chung SM. Characteristics of Lisch nodules in patients with neurofibromatosis type 1[J]. J Pediatr Ophthalmol Strabismus, 2003, 40(5): 293-296. DOI: 10.3928/0191-3913-20030901-11.
|
5. |
Nakakura S, Shiraki K, Yasunari T, et al. Quantification and anatomic distribution of choroidal abnormalities in patients with type Ⅰ neurofibromatosis[J]. Graefe’s Arch Clin Exp Ophthalmol, 2005, 243(10): 980-984. DOI: 10.1007/s00417-005-1184-z.
|
6. |
Kumar V, Singh S. Multimodal imaging of choroidal nodules in neurofbromatosis type-1[J]. Indian J Ophthalmol, 2018, 66(4): 856-858. DOI: 10.4103/ijo.IJO_1095_17.
|
7. |
Yasunari T, ShirakiI K, Hattori H, et al. Frequency of choroidal abnormalities in neurofibromatosis type 1[J]. Lancet, 2000, 356(9234): 988-992. DOI: 10.1016/S0140-6736(00)02716-1.
|
8. |
Tadini G, Milani D, Menn F, et al. Is it time to change the neurofibromatosis 1 diagnostic criteria?[J]. Eur J Intern Med, 2014, 25(6): 506-510. DOI: 10.1016/j.ejim.2014.04.004.
|